Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report

• Главные авторы: Boney Joseph (Автор), Nicolas A. Nunez (Автор), Simon Kung (Автор), Jennifer L. Vande Voort (Автор), Vanessa K. Pazdernik (Автор), Kathryn M. Schak (Автор), Stacey M. Boehm (Автор), Brooke Carpenter (Автор), Emily K. Johnson (Автор), Grigoriy Malyshev (Автор), Nathan Smits (Автор), Daniel O. Adewunmi (Автор), Sarah K. Brown (Автор), Balwinder Singh (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2023-08-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Intravenous (IV) ketamine and FDA-approved intranasal (IN) esketamine are increasingly used for treatment-resistant depression (TRD). Preliminary studies have suggested a synergistic effect of ketamine and lamotrigine, although the data are inconclusive. Herein, we report the response to serial keta...